The Physicians’ Labeling Rule: An Evaluation of ComplianceSpringer Science and Business Media LLC - Tập 45 - Trang 277-290 - 2011
Amy L. Ebel, Thomas G. Cantu, Stuart Hobbs, Paula R. Rogenes, Melissa Beaman, Maryann Ziemba
The primary purpose of this study was to evaluate compliance of newly approved labeling with the Physicians’ Labeling Rule (PLR). Labeling (prescribing information) for 221 products in PLR format approved during the first 30 months following the regulation effective date were compared with requirements set by the PLR regulation, as well as with available FDA guidances and prespecified best practic...... hiện toàn bộ
International Conference on Harmonization-Good Clinical Practices UpdateSpringer Science and Business Media LLC - Tập 32 - Trang 1143-1147 - 1998
Bette L. Barton
This paper presents an introduction to the “International Conference on Harmonization Good Clinical Practices Consolidated Guideline” for professionals who are already familiar with Food and Drug Administration (FDA) clinical trial standards. A brief background on the International Conference on Harmonization (ICH) is provided. ICH-GCP is then compared to FDA standards. ICH guidelines are well sup...... hiện toàn bộ
Product Launch and the Strategies, Processes, and Operations of Medical Affairs to Support Start-Up CompaniesSpringer Science and Business Media LLC - Tập 41 - Trang 743-759 - 2007
Ronald P. Evens, Mario Sylvestri
For a launch of the first product by a start-up company, the medical affairs (MA) team plays both strategic and operational roles. Launch presents a brand-new and urgent situation at a company with limited experiences, staff, and budget. A structured set of processes for analysis, planning, implementation, and follow-up are cited to assist a start-up in this new endeavor. This article discusses th...... hiện toàn bộ
Development of an Established Name: Analyzing Stem Based United States Adopted NamingSpringer Science and Business Media LLC - Tập 41 - Trang 661-672 - 2007
Patrick M. Carpenter, Robyn A. Bruce
Objectives: This retrospective analysis classifies US adopted naming (USAN) stems based on how the stem is defined. This analysis seeks to identify “commonalities” among stems, discuss medication errors due to drug name issues, identify inconsistencies of the stem-based naming system, and discuss possible solutions to the problem, including education of health care providers.Methods: Stems were ta...... hiện toàn bộ
Utilization of Drug Information Systems by Medical Representatives in the Japanese Pharmaceutical IndustrySpringer Science and Business Media LLC - Tập 32 - Trang 761-767 - 1998
Manai Yamamoto, Tomoko Iizuka, Hisako Negi, Mayumi Shimizu, Shoichi Funabashi, Seizaburo Okada
For full utilization of a drug information database system by users, education and support activities are indispensable. Daiichi Pharmaceutical Co., Ltd. ’s PMS Administration Department has facilitated familiarization of users with its in-house database systems and improved their utilization through an in-house training campaign, analysis of information retrieved (log files), feedback on the resu...... hiện toàn bộ
Measuring the Incidence, Causes, and Repercussions of Protocol AmendmentsSpringer Science and Business Media LLC - Tập 45 - Trang 265-275 - 2011
Kenneth A. Getz, Rachael Zuckerman, Anne B. Cropp, Anna L. Hindle, Randy Krauss, Kenneth I. Kaitin
Drug development companies frequently amend finalized clinical trial protocols. Yet the incidence, causes, and impact of protocol amendments have never been quantified. Tufts Center for the Study of Drug Development (Tufts CSDD) conducted a study, in collaboration with 17 large and midsized pharmaceutical and biotechnology companies, examining more than 3,400 clinical trial protocols across develo...... hiện toàn bộ
Emerging Trends in US Oncological Approvals: A 13-Year Review (1999–2011)Springer Science and Business Media LLC - Tập 46 - Trang 344-357 - 2012
Jing Huang, Wenze Zhang, Debra Bowen, Joemy Tam, Hsiaohui Wu, Man Fung
Advances in medicine, clinical trial design, and statistical methods affect product approvals. Over the last decade, there were many breakthroughs in the development of novel cancer therapies, including the wide application of biomarkers in drug development. Understanding trends and patterns of trial design and data submissions that lead to the approval of these novel agents assists oncologists, i...... hiện toàn bộ